Exchange Traded Concepts, LLC Compass Therapeutics, Inc. Call Options Transaction History
Exchange Traded Concepts, LLC
- $3.81 Billion
- Q1 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding CMPX
# of Institutions
80Shares Held
94.2MCall Options Held
0Put Options Held
0-
Orbimed Advisors LLC San Diego, CA22.4MShares$19.2 Million1.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA11.1MShares$9.57 Million0.04% of portfolio
-
Janus Henderson Group PLC London, X06.49MShares$5.58 Million0.01% of portfolio
-
Blackstone Inc New York, NY6.19MShares$5.32 Million0.05% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$5.19 Million0.0% of portfolio
About Compass Therapeutics, Inc.
- Ticker CMPX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 101,285,000
- Market Cap $87.1M
- Description
- Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...